1. Ng JH, Iyer NG, Tan MH, Edgren G. Changing epidemiology of oral squamous cell carcinoma of the tongue: A global study. Head Neck. 2017;39(2):297-304. [
Link] [
DOI:10.1002/hed.24589]
2. Anwar S, Tyagi N, Mathias YL, Javed D. A five year retrospective study of oral potentially malignant disorders (Opmds) and oral squamous cell carcinoma (OSCC) and their associated risk factors. J Datta Meghe Inst Med Sci Univ. 2023;18(3):460-7. [
Link] [
DOI:10.4103/jdmimsu.jdmimsu_94_23]
3. Akrish S, Eskander-Hashoul L, Rachmiel A, Ben-Izhak O. Clinicopathologic analysis of verrucous hyperplasia, verrucous carcinoma and squamous cell carcinoma as part of the clinicopathologic spectrum of oral proliferative verrucous leukoplakia: A literature review and analysis. Pathol Res Pract. 2019;215(12):152670. [
Link] [
DOI:10.1016/j.prp.2019.152670]
4. Monaghan NP, Duckett KA, Nguyen SA, Newman JG, Kejner AE, Albergotti WG. Agent orange and head and neck cancer: A systematic review and meta-analysis. World J Otorhinolaryngol Head Neck Surg. 2024;11(1):138-46. [
Link] [
DOI:10.1002/wjo2.198]
5. Lin X, Wu X, Gomaa A, Chen J, Wu L, Xie X, et al. Analysis of risk factors for multiple primary oral squamous cell carcinoma: A cohort study. Clin Oral Investig. 2020;24(9):3147-55. [
Link] [
DOI:10.1007/s00784-019-03189-0]
6. Katz J, Saleh W, Alharbi H, Farhadfar N. Multiple oral squamous cell carcinoma 6 years after allogeneic stem cell transplantation complicated with chronic graft-versus-host disease: A case report. SAGE Open Med Case Rep. 2022;10:2050313X221118203. [
Link] [
DOI:10.1177/2050313X221118203]
7. Poursaleh Z, Harandi AA, Vahedi E, Ghanei M. Treatment for sulfur mustard lung injuries; New therapeutic approaches from acute to chronic phase. Daru. 2012;20(1):27. [
Link] [
DOI:10.1186/2008-2231-20-27]
8. Razavi SM, Abdollahi M, Salamati P. Cancer events after acute or chronic exposure to sulfur mustard: A review of the literature. Int J Prev Med. 2016;7:76. [
Link] [
DOI:10.4103/2008-7802.182733]
9. Balali‐Mood M, Hefazi M. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol. 2006;99(4):273-82. [
Link] [
DOI:10.1111/j.1742-7843.2006.pto_429.x]
10. Kehe K, Szinicz L. Medical aspects of sulphur mustard poisoning. Toxicology. 2005;214(3):198-209. [
Link] [
DOI:10.1016/j.tox.2005.06.014]
11. Ghanei M, Harandi AA. Long term consequences from exposure to sulfur mustard: a review. Inhal Toxicol. 2007;19(5):451-6. [
Link] [
DOI:10.1080/08958370601174990]
12. Ebadi A, Moradian T, Mollahadi M, Saeed Y, Refahi AA. Quality of life in Iranian chemical warfare veteran's. Iran Red Crescent Med J. 2014;16(5):e5323. [
Link] [
DOI:10.5812/ircmj.5323]
13. Gupta B, Johnson NW, Kumar N. Global epidemiology of head and neck cancers: a continuing challenge. Oncology. 2016;91(1):13-23. [
Link] [
DOI:10.1159/000446117]
14. Cigic L, Martinovic D, Martinic J, Kovic M, Druzijanic A, Galic I, et al. Increased prevalence of oral potentially malignant lesions among Croatian War invalids, a cross-sectional study. J Clin Exp Dent. 2023;15(9):e734-41. [
Link] [
DOI:10.4317/jced.60715]
15. James T, Collins S, Marczylo T. Identification of novel simulants for toxic industrial chemicals and chemical warfare agents for human decontamination studies: A systematic review and categorisation of physicochemical characteristics. Int J Environ Res Public Health. 2021;18(16):8681. [
Link] [
DOI:10.3390/ijerph18168681]
16. Muhammad BA. Effects of chemical weapons on cancer development in human. Kurd J Appl Res. 2016;1(1):50-60. [
Link] [
DOI:10.24017/science.2016.1.1.5]
17. Zafarghandi MR, Soroush MR, Mahmoodi M, Naieni KH, Ardalan A, Dolatyari A, et al. Incidence of cancer in Iranian sulfur mustard exposed veterans: A long-term follow-up cohort study. Cancer Causes Control. 2013;24(1):99-105. [
Link] [
DOI:10.1007/s10552-012-0094-8]